Sonnet Biotherapeutics Holdings Inc (SONN) — Working Capital to Net Assets Ratio
Sonnet Biotherapeutics Holdings Inc (SONN) has a Working Capital to Net Assets ratio of 124.2% as of June 2025. Working capital of $-3.78 Million (current assets of $1.32 Million minus current liabilities of $5.10 Million) is measured against net assets of $-3.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SONN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sonnet Biotherapeutics Holdings Inc Working Capital to Net Assets (2007–2025)
This chart shows how Sonnet Biotherapeutics Holdings Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of June 2025, the ratio stands at 124.2%, reflecting working capital of $-3.78 Million against net assets of $-3.05 Million USD. See defensive interval ratio of Sonnet Biotherapeutics Holdings Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Sonnet Biotherapeutics Holdings Inc (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sonnet Biotherapeutics Holdings Inc from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Sonnet Biotherapeutics Holdings Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 95.0% | $10.25 Million | $10.79 Million | $14.34 Million | $4.10 Million | ▼ -129.9 pp |
| 2024 | 224.9% | $-1.09 Million | $-485.74K | $2.12 Million | $3.21 Million | ▼ -123.1 pp |
| 2023 | 348.0% | $-786.37K | $-225.98K | $4.74 Million | $5.52 Million | ▲ +239.6 pp |
| 2022 | 108.4% | $-2.75 Million | $-2.54 Million | $5.41 Million | $8.16 Million | ▲ +9.0 pp |
| 2021 | 99.3% | $22.11 Million | $22.26 Million | $28.81 Million | $6.70 Million | ▲ +2.9 pp |
| 2020 | 96.5% | $2.91 Million | $3.02 Million | $7.64 Million | $4.72 Million | ▼ -3.5 pp |
| 2019 | 100.0% | $-2.85 Million | $-2.85 Million | $39.75K | $2.89 Million | ▲ +241.5 pp |
| 2018 | -141.5% | $-11.68 Million | $8.26 Million | $1.34 Million | $13.03 Million | ▼ -28.9 pp |
| 2017 | -112.6% | $-12.93 Million | $11.49 Million | $1.80 Million | $14.73 Million | ▼ -38.7 pp |
| 2016 | -73.9% | $-10.32 Million | $13.96 Million | $1.79 Million | $12.11 Million | ▼ -17.1 pp |
| 2015 | -56.8% | $-12.36 Million | $21.76 Million | $3.82 Million | $16.18 Million | ▲ +9.6 pp |
| 2015 | -66.4% | $-9.94 Million | $14.97 Million | $1.47 Million | $11.41 Million | ▼ -32.4 pp |
| 2013 | -34.0% | $-3.82 Million | $11.24 Million | $1.71 Million | $5.53 Million | ▲ +0.0 pp |
| 2013 | -34.0% | $-3.82 Million | $11.24 Million | $1.71 Million | $5.53 Million | ▲ +149.0 pp |
| 2012 | -183.0% | $-3.00 Million | $1.64 Million | $623.68K | $3.63 Million | ▲ +407.7 pp |
| 2011 | -590.7% | $-486.92 Million | $82.42 Million | $158.72 Million | $645.63 Million | ▼ -512.2 pp |
| 2009 | -78.5% | $-563.63K | $718.02K | $60.18K | $623.82K | ▼ -36.0 pp |
| 2008 | -42.5% | $-654.77K | $1.54 Million | $23.56K | $678.33K | ▼ -33.9 pp |
| 2007 | -8.6% | $-300.48K | $3.48 Million | $18.90K | $319.38K | — |